Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma; Small Cell Variant: A Real Diagnostic Challenge. Case Presentation and Review of Literature.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
09 Mar 2020
Historique:
entrez: 10 3 2020
pubmed: 10 3 2020
medline: 1 12 2020
Statut: epublish

Résumé

BACKGROUND Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL) both have a common origin arising from mature CD5+ B-lymphocytes. Their distinction is crucial since MCL is a considerably more aggressive disease. Composite lymphoma consisting of CLL/SLL and MCL has been rarely reported. This type of composite lymphoma may be under-diagnosed as the 2 neoplasms have many features in common, both morphologically and immunophenotypically. CASE REPORT We report the case of a 57-year-old male patient who presented with a 4-month history of recurrent abdominal pain and distention with hepatosplenomegaly. Peripheral blood showed a high leukocytes count (46.7×10³/uL) with marked lymphocytosis of 35.0×10³/uL, mostly small mature-looking, with some showing nuclear irregularities, with approximately 3% prolymphocytes. Immunophenotyping by flow cytometry and immunohistochemistry revealed 2 immunophenotypically distinct abnormal CD5+monotypic B-cell populations. Fluorescence in situ hybridization (FISH) on peripheral blood demonstrated IGH/CCND1 rearrangement consistent with t(11;14) in 65% of cells analyzed. Accordingly, based on compilation of findings from morphology, flow cytometry, immunohistochemistry, and FISH, A diagnosis of composite lymphoma consisting of MCL; small cell variant and CLL/SLL was concluded. CONCLUSIONS We describe a case of composite lymphoma of MCL (small cell variant) and CLL/SLL that emphasizes the crucial role of the multiparametric approach, including vigilant cyto-histopathologic examination, immunophenotyping by flow cytometry and immunohistochemistry, as well as genetic testing, to achieve the correct diagnosis.

Identifiants

pubmed: 32150530
pii: 921131
doi: 10.12659/AJCR.921131
pmc: PMC7083592
doi:

Substances chimiques

Biomarkers, Tumor 0
IGH-CCND1 fusion protein, human 0
Oncogene Proteins, Fusion 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e921131

Références

Diagn Pathol. 2011 Jul 06;6:60
pubmed: 21733146
Maedica (Buchar). 2014 Jun;9(2):204-9
pubmed: 25705280
Cytometry B Clin Cytom. 2003 Jan;51(1):41-4
pubmed: 12500296
Hum Pathol. 2013 Jan;44(1):110-21
pubmed: 22944294
Acta Haematol. 2011;126(1):40-3
pubmed: 21430370
Am J Pathol. 1999 Jun;154(6):1857-66
pubmed: 10362812
Pathol Res Pract. 2017 Nov;213(11):1378-1383
pubmed: 28974340
Ann Hematol. 2012 Oct;91(10):1649-51
pubmed: 22395437
J Clin Pathol. 2015 Jun;68(6):473-8
pubmed: 25713417
Arch Pathol Lab Med. 2006 Jan;130(1):107-12
pubmed: 16390224
Acta Haematol. 2010;123(3):194-6
pubmed: 20234130
Blood. 2004 Apr 1;103(7):2795-8
pubmed: 14551145
Int J Hematol. 2013 Nov;98(5):589-96
pubmed: 24061774
Am J Clin Pathol. 2011 Apr;135(4):541-55
pubmed: 21411776
Pathol Int. 2012 Oct;62(10):690-8
pubmed: 23005596
Mod Pathol. 2011 Nov;24(11):1433-43
pubmed: 21685909
Cytometry B Clin Cytom. 2018 Jan;94(1):148-150
pubmed: 28109040
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949

Auteurs

Feryal Ibrahim (F)

Department of Laboratory Medicine and Pathology, National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation, Doha, Qatar.

Ahmad Al Sabbagh (A)

Department of Laboratory Medicine and Pathology, National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation, Doha, Qatar.

Aliaa Amer (A)

Department of Laboratory Medicine and Pathology, Central Clinical Laboratory, Hamad Medical Corporation, Doha, Qatar.

Dina S Soliman (DS)

Department of Laboratory Medicine and Pathology, National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation, Doha, Qatar.
Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.

Hesham Al Sabah (H)

Department of Hematology and Medical Oncology, National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation, Doha, Qatar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH